Summary by Futu AI
KYOTO HEALTH CO., LTD. (“KYOTO HEALTH”) HAS ANNOUNCED UNAUDITED FINANCIAL DATA FOR THE FIRST QUARTER OF 2024. The report showed that in the quarter, revenue from Kyoto Health declined 4.9% compared to the same period last year to RMB13,267,397 thousand; operating profit fell 38.7% to RMB487,316 thousand; Non-International Financial Reporting Criteria operating profit fell 34.8% to RMB754,380 thousand. The company emphasizes that these preliminary data have not been audited or reviewed by auditors and are subject to change. In terms of business, Kyodo Health launched a number of new specialty drugs in the first quarter and launched a “retirement channel” to meet the needs of home nursing consumers, while strengthening its online and downstream integrated service capabilities. The announcement was made on 16 May 2024 by the Representative Board of Mr. Kim Enlin, Executive Director.